PREDICTING MED
MARSEILLE / 70 RUE SAINTE
|
PREDICTING MED is a start up based in Grand Luminy, Marseilles which owns and manages CRCM (Cancer Research Center of Marseille)’s patent from SATT Sud Est (Technology Transfer company). PREDICTING MED company is supported by Upper Side Capital Partners holding and MRS Participations start up studio. Involved in University start up incubator program by Impulse, PREDICTING MED is also a BPI laureate (Deep Tech Label and BPI French Tech grant). The company is providing Pancreas View, a pronostic and theranostic pancreatic cancer test. PREDICTING MED is involved in various networks as French Care, Comité Richelieu and NETVA 2023 laureate program to develop US market. To learn more about it : https://predictingmed.com/ |
|||||||||
| Business axis : |
Diagnostic
|
||||||||
| Category : | TPE | ||||||||
| Legal form : | SAS | ||||||||
| Website : | www.predictingmed.com | ||||||||
| Turnover : |
0.00 K€ |
||||||||